Form 4: Thermopylae Holdings Ltd. Increases Stake in AbCellera Biologics Inc.
SEC Form 4 Filing
Thermopylae Holdings Ltd. reports purchasing 343,631 common shares of AbCellera Biologics Inc. at an average price of $2.16 per share, increasing its total holdings to 56,143,640 shares.
Summary
- On March 11, 2025, Thermopylae Holdings Ltd. acquired 343,631 common shares of AbCellera Biologics Inc.
- The shares were purchased at a weighted-average price of $2.16.
- The transactions occurred at prices ranging from $2.12 to $2.23.
- Following the reported transaction, Thermopylae Holdings Ltd. beneficially owns 56,143,640 common shares of AbCellera Biologics Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase indicates confidence from a major shareholder, but it's a routine transaction.
Positives
- Increased investment by a major shareholder could be seen as a positive signal for AbCellera Biologics Inc.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a change in ownership by a significant shareholder, which is common in publicly traded companies.
Stakeholder Impact
- The increased stake by Thermopylae Holdings Ltd. could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of transaction: Thermopylae Holdings Ltd. acquired 343,631 common shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.